Marie Thibault
Stock Analyst at BTIG
(0.05)
# 4,636
Out of 4,659 analysts
740
Total ratings
40%
Success rate
-9.6%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBLL CeriBell | Reiterated: Buy | $28 → $30 | $24.21 | +23.92% | 13 | Aug 18, 2026 | |
| SENS Senseonics Holdings | Maintained: Hold | n/a | $8.69 | - | 40 | Aug 7, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $185 | $115.24 | +60.53% | 62 | Aug 7, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2 | $0.8957 | +123.29% | 5 | Aug 7, 2026 | |
| PODD Insulet | Downgraded: Hold | n/a | $148.03 | - | 51 | Aug 6, 2026 | |
| DXCM DexCom | Reiterated: Buy | $80 → $90 | $89.60 | +0.45% | 56 | Jul 31, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $45 | $45.76 | -1.66% | 53 | Jul 24, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $90.98 | +20.91% | 44 | Jul 24, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $131 → $134 | $112.68 | +18.92% | 53 | Jul 16, 2026 | |
| KMTS Kestra Medical Technologies | Reiterated: Buy | $30 → $32 | $27.93 | +14.57% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $17 | $16.86 | +0.83% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $50.47 | +28.79% | 78 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.73 | - | 16 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $19.36 | +29.13% | 4 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.315 | - | 39 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 | $104.65 | -19.73% | 13 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.10 | - | 28 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.66 | - | 8 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $4.18 | +258.85% | 18 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $75.22 | n/a | 55 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $310.03 | n/a | 1 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $324.75 | n/a | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 37 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $89 | $92.09 | n/a | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.15 | n/a | 23 | Dec 16, 2022 |
CeriBell
Aug 18, 2026
Reiterated: Buy
Price Target: $28 → $30
Current: $24.21
Upside: +23.92%
Senseonics Holdings
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $8.69
Upside: -
iRhythm Holdings
Aug 7, 2026
Reiterated: Buy
Price Target: $185
Current: $115.24
Upside: +60.53%
Hyperfine
Aug 7, 2026
Reiterated: Buy
Price Target: $2
Current: $0.8957
Upside: +123.29%
Insulet
Aug 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $148.03
Upside: -
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $90
Current: $89.60
Upside: +0.45%
AtriCure
Jul 24, 2026
Reiterated: Buy
Price Target: $45
Current: $45.76
Upside: -1.66%
Edwards Lifesciences
Jul 24, 2026
Reiterated: Buy
Price Target: $110
Current: $90.98
Upside: +20.91%
Abbott Laboratories
Jul 16, 2026
Maintained: Buy
Price Target: $131 → $134
Current: $112.68
Upside: +18.92%
Kestra Medical Technologies
Jul 15, 2026
Reiterated: Buy
Price Target: $30 → $32
Current: $27.93
Upside: +14.57%
Jul 13, 2026
Maintained: Buy
Price Target: $16 → $17
Current: $16.86
Upside: +0.83%
Jul 10, 2026
Maintained: Buy
Price Target: $65
Current: $50.47
Upside: +28.79%
Jul 10, 2026
Maintained: Hold
Price Target: n/a
Current: $5.73
Upside: -
Jul 9, 2026
Maintained: Buy
Price Target: $25
Current: $19.36
Upside: +29.13%
Jul 7, 2026
Rated: Hold
Price Target: n/a
Current: $0.315
Upside: -
Jun 26, 2026
Reiterated: Buy
Price Target: $84
Current: $104.65
Upside: -19.73%
Jun 15, 2026
Maintained: Hold
Price Target: n/a
Current: $5.10
Upside: -
Feb 18, 2026
Maintained: Hold
Price Target: n/a
Current: $5.66
Upside: -
Feb 18, 2026
Maintained: Buy
Price Target: $15
Current: $4.18
Upside: +258.85%
Apr 10, 2025
Reiterated: Buy
Price Target: $62
Current: $75.22
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $150
Current: $310.03
Upside: n/a
Jul 26, 2023
Rated: Buy
Price Target: n/a
Current: $324.75
Upside: n/a
Jul 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Feb 21, 2023
Rated: Hold
Price Target: $89
Current: $92.09
Upside: n/a
Dec 16, 2022
Rated: Hold
Price Target: n/a
Current: $3.15
Upside: n/a